• Gradual Volume Restoration – Rebuilds facial fullness through natural collagen activation.
• Improves Skin Elasticity – Enhances firmness and structure with bio-compatible poly-L-lactic acid.
• Long-Lasting Anti-Aging Effect – Results can remain visible for up to 24 months.
• Safe & Fully Absorbable – Biodegradable formula integrates smoothly into treatment plans.
• Smooth, Even Skin Texture – Reduces fine lines, sagging, and uneven tone over time.
Natural Volume and Skin Elasticity Through Targeted Collagen Stimulation
aesPLLA® is a professional mesotherapy product developed by Oreon Life Science for specialists who focus on visible skin revitalization and long-lasting volume enhancement. The formulation is based on poly-L-lactic acid, a bio-compatible biomaterial that is fully metabolized by the body. Once applied, aesPLLA® activates the natural collagen synthesis of the skin. This biological response supports firmer skin, improves skin structure, and helps keep moisture levels balanced. Over time, the skin can look smoother, fresher, and more even, while keeping a natural appearance. Due to its controlled action, this collagen stimulator fits well into advanced facial rejuvenation concepts that focus on stable, long-term quality results.
Long-Lasting Rejuvenation With Bio-Compatible Poly-L-Lactic Acid
The effectiveness of aesPLLA® is based on the slow, progressive activity of polylactic acids that gently trigger the skin’s regenerative processes. This controlled stimulation supports a gradual increase in skin elasticity and facial volume. Fine lines and light wrinkles can appear softer, while sagging areas may look firmer over time. The fully biodegradable material integrates safely into professional treatment plans and supports stable, predictable results. Because the effect develops slowly, the skin can adapt naturally, and visible improvements can remain noticeable for up to one to two years, depending on skin condition and professional application protocols.
FAQs
For which facial areas is aesPLLA® suitable?
aesPLLA® can be used on several zones of the face, including temples, eye area, cheeks, nasolabial folds, marionette lines, and larger facial regions where volume support and skin tightening are required.
Which skin concerns can be improved with aesPLLA®?
The product supports collagen production and helps balance skin moisture. This leads to a firmer skin surface, a fresher appearance, and a more even tone while reducing the visibility of wrinkles, sagging areas, and darkened spots.
What is included in one package of aesPLLA®?
Each package contains one ampoule filled with 5 ml of product.
Which main component is used in aesPLLA®?
The formulation is primarily composed of 365 mg of poly-L-lactic acid.
How is aesPLLA® prepared before professional use?
Before application, the product should be combined with 5 ml of sterile distilled water and 2 ml of lidocaine. Preparation should take place between 30 minutes and two hours prior to injection, following the official protocol.
When do results usually become visible?
Visible improvements generally develop within four to six weeks after treatment, although timing may vary depending on skin type, skin structure, and professional treatment planning.
How many sessions are recommended?
Optimal results are commonly achieved with two to three mesotherapy sessions, spaced at intervals of approximately six weeks.
How long can the results last?
The aesthetic improvements achieved with aesPLLA® can remain visible for one to two years, depending on individual skin condition and care routines.
In which skin layer should aesPLLA® be injected?
Professional application is performed in the subcutaneous dermis using a 21G or 23G needle.
Which injection technique is recommended?
The punctured fan technique is advised, as it supports even distribution and consistent results.
What injection volumes are used for different facial areas?
The applied amount varies by region. Typical volumes range from 2 to 3 ml per temple, 1 to 1.5 ml per lacrimal sac, 2 to 2.5 ml per cheek, 2 to 2.5 ml per nasolabial fold, 1 to 1.5 ml per marionette line, and around 6 ml for larger facial zones.
Distribution is permissible solely upon presentation of a valid medical prescription. This directive does not pertain to individuals engaged in the field of healing or healthcare.
Both the manufacturer and we, in our capacity as the vendor, stress the importance of injections involving products containing or lacking lidocaine being administered solely by proficient and medically qualified personnel.
